ZHANG, BEILI,KRAWIEC, MARIUSZ,BOTFIELD, MARTYN,GROOTENHUIS, PETER, D
申请号：
NZ59250409
公开号：
NZ592504A
申请日:
2009.10.23
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
592504 The present disclosure relates to solid state forms, for example, crystalline forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide - compound 1, pharmaceutical compositions thereof, and methods therewith. The Form A is characterized by one or more peaks in an X-ray powder diffraction pattern selected from about 7.9, about 9.3, about 11.9, about 14.4, about 15.1, about 15.8, about 17.0, about 17.7, about 19.3, about 20.1, about 21.4, about 21.8, about 23.4, about 23.8, about 25.6, about 26.8, about 29.4, about 29.7, about 30.1 or about 31.2 degrees 2 theta.
